Prot #AT148002: A Phase 1/2 Study of ALX148 in Combination with Azacitidine in Patients with Higher Risk Myelodysplastic Syndrome (MDS)

Project: Research project

Project Details

StatusActive
Effective start/end date9/23/20 → 9/23/23

Funding

  • Novella Clinical, LLC (Prot #AT148002)
  • ALX Oncology, Inc (Prot #AT148002)